Fortney Kristen bought BIOA
February 17, 2026 · Form 4 insider transaction
Fortney Kristen bought 330,000 shares of BioAge Labs, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
330,000
Price
$0.00
Total value
N/A
InsiderFortney Kristen
RoleOfficer, Director
CompanyBioAge Labs, Inc. (BIOA)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after330,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on February 1, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.